GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Lantheus Holdings Inc.
Lantheus is a leader in medical diagnostics, particularly in nuclear medicine and echocardiography. Its stock price soared on the success of its Definity contrast agent and its new Pylarify product for prostate cancer PET imaging. It's a story of diagnostic innovation.
Share prices of companies in the market segment - Heart
Lantheus is a leader in medical diagnostics, including contrast agents and radiopharmaceuticals. We classify it as part of the Cardiology Drugs and Diagnostics sector, and the chart below illustrates the overall dynamics of this field, driven by innovations in disease imaging.
Broad Market Index - GURU.Markets
Lantheus is a leader in medical diagnostics, developing and marketing radiopharmaceuticals and contrast agents for cardiac and other organ imaging. As a component of the GURU.Markets index, the company sits at the intersection of pharmaceuticals and medical technology. The chart below represents the entire market. See how Lantheus shares compare to the overall trend.
Change in the price of a company, segment, and market as a whole per day
LNTH - Daily change in the company's share price Lantheus Holdings Inc.
The daily price change of Lantheus, a leader in diagnostic imaging, is a measure of its sensitivity to medical innovation. Change_co reflects the volatility associated with new product approvals and their commercial success. This metric is important for formulas on System.GURU.Markets that analyze the medical technology sector.
Daily change in the price of a set of shares in a market segment - Heart
Lantheus Holdings, Inc. is a leader in diagnostic imaging. This chart highlights the high volatility of the MedTech sector. Comparing it to LNTH, with its radiopharmaceuticals and contrast agents, helps us appreciate its unique market position.
Daily change in the price of a broad market stock, index - GURU.Markets
Lantheus is a leader in radiopharmaceuticals and diagnostic imaging. The medical technology market is growing rapidly. The chart below shows the volatility in this sector, helping to assess how Lantheus shares respond to innovation and competition.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Lantheus Holdings Inc.
Lantheus is a leader in radiopharmaceuticals for medical diagnostics. Its year-over-year performance reflects its rapid growth and the adoption of its technologies in clinical practice. The chart below tells the story of this medical technology leader, transforming approaches to diagnostics.
Annual dynamics of market capitalization of the market segment - Heart
Lantheus Holdings, Inc. is a leader in diagnostic imaging and targeted radiotherapy. Its innovative products help detect and treat diseases, particularly in cardiology and oncology. The chart shows how its technological advantage and strong product portfolio enable its superior growth.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Lantheus, a leader in diagnostic imaging, is a growth story in medicine. Its stock price is driven not by the economy, but by demand for its innovative drugs that help doctors "see" diseases. The chart reflects how a breakthrough technology can create and capture a new market.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Lantheus Holdings Inc.
The performance of Lantheus, a leader in diagnostic imaging, depends on its product cycle. The monthly fluctuations on the chart reflect the growth of its radiopharmaceuticals, particularly PYLARIFY for prostate cancer diagnostics, which is a key driver of its phenomenal growth.
Monthly dynamics of market capitalization of the market segment - Heart
Lantheus Holdings is a leader in medical diagnostics, particularly in the development and sale of radiopharmaceuticals for cardiac and oncology imaging. Their products help doctors "see" diseases. The chart below shows the overall dynamics of the medical technology sector, where innovation saves lives.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Lantheus is a leader in radiopharmaceuticals and diagnostic medical imaging, particularly in cardiology and oncology. The chart below shows general market trends, but Lantheus shares move with news of the approval and introduction of its innovative products, not the market as a whole.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Lantheus Holdings Inc.
Lantheus, a leader in diagnostic imaging and radiopharmaceuticals, is at the intersection of medicine and technology. The company's weekly stock performance reflects news of new diagnostic drug approvals, clinical trial data, and demand for advanced diagnostic methods in cardiology and oncology.
Weekly dynamics of market capitalization of the market segment - Heart
The diagnostic imaging sector, where Lantheus operates, is benefiting from the overall aging of the population and advances in medicine. The graph below shows the dynamics of this growing segment. It allows one to assess the success of Lantheus's new products and how they help the company outpace its competitors' growth rates.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Lantheus Holdings is a leader in medical diagnostics, particularly cardiac imaging. Demand for its products is growing due to an aging population. This chart helps assess how this stable demand and product innovations are impacting stock performance amid a volatile market.
Market capitalization of the company, segment and market as a whole
LNTH - Market capitalization of the company Lantheus Holdings Inc.
Lantheus's market capitalization chart reflects the market's assessment of its leadership in diagnostic imaging. Its explosive growth reflects the tremendous success of its PYLARIFY prostate cancer PET imaging drug. The scale of this metric demonstrates how a single innovative product can radically change a company and the standards of medical diagnostics.
LNTH - Share of the company's market capitalization Lantheus Holdings Inc. within the market segment - Heart
Lantheus Holdings is a leader in the diagnostic imaging market, particularly in cardiology. Its dominant share of the cardiac ultrasound contrast agent segment reflects its ability to provide physicians with critical diagnostic tools.
Market capitalization of the market segment - Heart
This graph shows the total value of the entire medical diagnostics sector, specifically radiopharmaceuticals. For Lantheus, a leader in the production of contrast agents for ultrasound and nuclear medicine, this line represents the development of imaging technologies. The rising graph indicates the increasing use of precision diagnostic methods in cardiology and oncology.
Market capitalization of all companies included in a broad market index - GURU.Markets
Lantheus Holdings is a leader in diagnostic imaging, particularly in cardiology. Its market capitalization is the market valuation of technologies that allow doctors to "look" inside the body. This represents a share of innovations that improve diagnostic accuracy and save lives.
Book value capitalization of the company, segment and market as a whole
LNTH - Book value capitalization of the company Lantheus Holdings Inc.
Lantheus Holdings is a leader in medical diagnostics, particularly in cardiology. Its book value comes from its production facilities for creating radiopharmaceuticals, its R&D laboratories, and its patents. This is the material basis for "seeing" diseases. How has this important infrastructure grown? The chart below shows the dynamics.
LNTH - Share of the company's book capitalization Lantheus Holdings Inc. within the market segment - Heart
Lantheus Holdings, Inc. is a leader in medical diagnostics, and its innovation is underpinned by its manufacturing capabilities. The company's balance sheet reflects the value of the factories and laboratories where radiopharmaceuticals and contrast agents are produced. The chart shows its share of the physical infrastructure for diagnostic manufacturing.
Market segment balance sheet capitalization - Heart
Lantheus Holdings is a leader in medical diagnostics. Compared to the capital-intensive healthcare sector, its model is knowledge-intensive. Its asset portfolio is enormous. Lantheus invests in the production and R&D of radiopharmaceuticals and contrast agents.
Book value of all companies included in the broad market index - GURU.Markets
Lantheus Holdings is a leader in medical diagnostics. The company's book value is derived from its production facilities for radiopharmaceuticals and ultrasound microbubbles, as well as its R&D centers. The chart shows the physical value of this company, whose assets help doctors "see" diseases at an early stage.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Lantheus Holdings Inc.
Lantheus is a leader in medical diagnostics. The chart shows the enormous premium the market pays for its patented radiopharmaceuticals and diagnostic agents. This is a valuation not of its manufacturing facilities, but of its intellectual property, which is the gold standard in many procedures.
Market to book capitalization ratio in a market segment - Heart
Lantheus Holdings is a leader in diagnostic imaging and targeted radiotherapy. Its products help doctors see and treat diseases, particularly cancer and heart disease. The chart shows the market premium paid for its innovative diagnostic and therapeutic platforms.
Market to book capitalization ratio for the market as a whole
Lantheus Holdings is a leader in medical diagnostics, developing and marketing radiopharmaceuticals and contrast agents for imaging. Its products help doctors "see" diseases. This chart reflects overall valuations, but how do investors view a company whose technologies make medical diagnostics more accurate and effective?
Debts of the company, segment and market as a whole
LNTH - Company debts Lantheus Holdings Inc.
Lantheus, a leader in diagnostic imaging, is using its financial strategy to strengthen its position. Capital can be used to fund research into new radiopharmaceuticals, expand production, and acquire companies with complementary technologies, allowing it to remain at the forefront of medical diagnostics.
Market segment debts - Heart
Lantheus Holdings is a leader in diagnostic imaging and targeted radiotherapy. The development and marketing of such complex medical products requires significant investment. This chart shows how the company funds its innovation and commercialization of products in the high-tech healthcare sector.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Lantheus Holdings Inc.
Lantheus Holdings is a leader in diagnostic imaging and targeted radiotherapy. This chart shows how the company finances the development and commercialization of its innovative products. Debt management is essential for funding clinical trials, acquisitions, and expanding manufacturing capacity to meet growing demand.
Market segment debt to market segment book capitalization - Heart
Developing diagnostic drugs for medical use, Lantheus's specialty, requires significant investment in research and regulatory approvals. This chart shows the overall debt burden in the sector. It allows one to assess how Lantheus, a leader in its niche, finances new product development and how its financial structure compares to pharmaceutical giants.
Debt to book value of all companies in the market
This chart is a barometer of the overall economy's debt burden. Lantheus, which operates in medical diagnostics, requires investment in research and equipment. A comparison with the overall market allows us to assess how the capital-intensive nuclear medicine niche differs from the financial policies of the average stock market company.
P/E of the company, segment and market as a whole
P/E - Lantheus Holdings Inc.
This chart for Lantheus Holdings, a leader in diagnostic imaging and radiopharmaceuticals, shows how investors value its innovative products. The high multiple reflects confidence in growing demand for advanced diagnostics, particularly in cardiology and oncology, where the company's products play a key role.
P/E of the market segment - Heart
Medical diagnostics, where Lantheus is a leader in radiopharmaceuticals, is a high-tech sector. This chart shows the average valuation for healthcare companies. It helps understand the premium investors are paying for Lantheus's dominant position and its innovative diagnostic products for cardiology and oncology.
P/E of the market as a whole
Lantheus Holdings, Inc. is a leader in the development, production, and commercialization of innovative diagnostic and therapeutic agents, particularly in cardiac imaging. This chart reflects the overall sentiment in the healthcare sector. It helps us understand whether LNTH's valuation reflects confidence in its unique products or whether it is moving in line with overall trends in medical diagnostics.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Lantheus Holdings Inc.
Lantheus Holdings is a leader in diagnostic imaging and targeted radiotherapy. Its products help doctors detect and treat diseases, particularly cancer and heart disease. This chart reflects market expectations for growing demand for advanced diagnostics. It demonstrates analysts' confidence in the commercial success of its innovative drugs.
%20P%2FE%20Lantheus%20Holdings%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Lantheus-Holdings-Inc.&v=1772648321698 "Chart of the company's future (projected) P/E Lantheus Holdings Inc.")
Future (projected) P/E of the market segment - Heart
Lantheus Holdings is a leader in diagnostic imaging and targeted radiopharmaceuticals, helping physicians detect and treat diseases, primarily cardiovascular and oncological. This chart displays the company's expected future profitability, allowing us to assess its innovative potential in advanced medicine.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Heart&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Heart&v=1772648321706 "Future (projected) P/E graph of the market segment - Heart")
Future (projected) P/E of the market as a whole
Lantheus Holdings is a leader in diagnostic imaging and targeted oncology. The company produces radiopharmaceuticals that help detect and treat cancer. Demand for its products is driven by medical needs and is independent of the economy, making Lantheus a growth story in the healthcare sector, regardless of market forecasts.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772648321736 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Lantheus Holdings Inc.
Lantheus Holdings, Inc. is a leader in diagnostic imaging and targeted radiotherapy. The company's profits depend on sales of its radiopharmaceuticals, which help doctors see and treat diseases, primarily cancer and heart disease. This chart shows how innovations in medical diagnostics and therapy are driving growing demand for Lantheus products.
Profit of companies in the market segment - Heart
Lantheus Holdings is a leader in medical diagnostics, developing and marketing radiopharmaceuticals and contrast agents for imaging. Its product, PYLARIFY, has revolutionized prostate cancer diagnostics. This chart demonstrates the high profitability of the diagnostic pharmaceutical sector, where innovative products can quickly become standard treatment.
Overall market profit
Lantheus Holdings is a leader in diagnostic imaging and radiopharmaceuticals. Demand for its products depends on the volume of medical procedures. The overall economic situation, reflected in this graph, influences healthcare budgets and insurance coverage, which in turn determines the availability of such procedures for patients.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Lantheus Holdings Inc.
Lantheus Holdings is a leader in diagnostic imaging and targeted radiotherapy. The company's products, such as contrast agents and radiopharmaceuticals, help doctors see and treat diseases, particularly in cardiology and oncology. This chart shows how analysts estimate future demand for innovative diagnostic and treatment methods.
%20profit%20of%20the%20company%20Lantheus%20Holdings%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Lantheus-Holdings-Inc.&v=1772648321789 "Graph of future (projected) profit of the company Lantheus Holdings Inc.")
Future (predicted) profit of companies in the market segment - Heart
Lantheus Holdings is a leader in diagnostic imaging and targeted radiotherapy. The company's products, such as contrast agents and radiopharmaceuticals, help doctors diagnose and treat cardiovascular diseases and cancer. This chart shows profitability projections for the healthcare sector, providing context for assessing Lantheus's role in modern medicine.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Heart&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Heart&v=1772648321802 "Graph of future (predicted) profits of companies in a market segment - Heart")
Future (predicted) profit of the market as a whole
Lantheus Holdings is a leader in medical diagnostics, particularly in nuclear medicine and echocardiography. Demand for its products is driven by the volume of diagnostic procedures, which is driven by demographic factors and healthcare trends rather than economic conditions. This makes the company's business stable and non-cyclical.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772648321820 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Lantheus Holdings Inc.
Lantheus Holdings is a leader in diagnostic imaging and radiopharmaceuticals. This chart shows the high premium investors pay for its earnings. This valuation reflects the dominant market position of its products and innovation in precision cancer diagnostics and treatment.
P/S market segment - Heart
Lantheus Holdings, Inc. is a leader in the development and commercialization of diagnostic and therapeutic imaging solutions for the medical field. This chart shows the average revenue estimate in the medical technology sector. It provides an indication of the premium investors are willing to pay for Lantheus's innovative products, which play a key role in cardiovascular diagnostics.
P/S of the market as a whole
Lantheus Holdings is a leader in diagnostic imaging and targeted radiotherapy. Their products, such as contrast agents and radiopharmaceuticals, help doctors see and treat diseases, particularly cancer and heart disease. This chart provides a general measure of revenue, highlighting the importance of LNTH's innovations to modern medicine.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Lantheus Holdings Inc.
Lantheus Holdings is a leader in diagnostic imaging and targeted oncology. The company develops radiopharmaceuticals that help doctors detect and treat diseases, primarily cardiovascular diseases and cancer. This chart reflects investor expectations for sales of its innovative diagnostic and therapeutic products.
%20P%2FS%20Lantheus%20Holdings%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Lantheus-Holdings-Inc.&v=1772648321861 "The graph of the company's future (projected) P/S Lantheus Holdings Inc.")
Future (projected) P/S of the market segment - Heart
Lantheus Holdings is a leader in the development and commercialization of innovative diagnostic and therapeutic solutions that help physicians detect and treat diseases, particularly in oncology and cardiology. This chart compares investor valuations of its specialized products in medical imaging and radiopharmaceuticals.
%20P%2FS%20market%20segment%20graph%20-%20Heart&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Heart&v=1772648321883 "Future (projected) P/S market segment graph - Heart")
Future (projected) P/S of the market as a whole
Lantheus Holdings is a leader in diagnostic imaging, producing contrast agents and radiopharmaceuticals for the detection of heart disease and cancer. This graph, reflecting overall economic expectations, impacts healthcare budgets. Stable economic growth allows medical institutions to invest in advanced diagnostic technologies, increasing demand for Lantheus products.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772648321907 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Lantheus Holdings Inc.
Lantheus Holdings is a leader in diagnostic imaging and targeted radiotherapy. This chart shows revenue from sales of innovative radiopharmaceuticals that help doctors diagnose and treat cardiovascular and oncological diseases. The growth here reflects the implementation of advanced medical technologies in clinical practice.
Sales of companies in the market segment - Heart
Lantheus Holdings, Inc. is a leader in the development and commercialization of diagnostic and therapeutic solutions, particularly in cardiology and oncology. Its business is divided into diagnostic imaging and targeted therapy segments. This chart shows revenue from one of these key areas, reflecting the demand for innovative medical solutions.
Overall market sales
Lantheus Holdings, Inc. is a leader in medical diagnostics, particularly in cardiac imaging and cancer diagnostics. Demand for its products is driven by healthcare needs and is independent of economic cycles. The company helps physicians make accurate diagnoses, which improves treatment outcomes and is a vital part of the modern healthcare system.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Lantheus Holdings Inc.
Lantheus Holdings is a leader in diagnostic imaging and targeted radiotherapy. The company's sales forecast reflects demand for its radiopharmaceuticals used in cardiology and oncology. It also highlights the expected growth in the use of its key cardiac stress testing product and the potential of new drugs for cancer diagnostics and treatment.
%20sales%20of%20the%20company%20Lantheus%20Holdings%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Lantheus-Holdings-Inc.&v=1772648321945 "Schedule of future (projected) sales of the company Lantheus Holdings Inc.")
Future (projected) sales of companies in the market segment - Heart
Lantheus Holdings, Inc. is a leader in diagnostic imaging and targeted radiotherapy, particularly in cardiology and oncology. This chart shows revenue expectations for the medical technology sector. It reflects analysts' views on the growing demand for advanced diagnostic methods that enable early disease detection.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Heart&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Heart&v=1772648321948 "Schedule of future (projected) sales of companies in the market segment - Heart")
Future (projected) sales of the market as a whole
Lantheus Holdings, a leader in medical diagnostics, particularly in cardiology, depends on the volume of procedures performed. This graph of overall sales forecasts reflects the state of the economy, which impacts healthcare budgets and patients' ability to afford the advanced diagnostic tests offered by Lantheus.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772648321951 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Lantheus Holdings Inc.
Lantheus Holdings, Inc. is a leader in diagnostic imaging and targeted radiotherapy. The company develops and markets drugs that help doctors diagnose and treat serious diseases, particularly cardiovascular and oncological ones. This chart shows how innovations in medical diagnostics translate into a high share of sales revenue.
Market segment marginality - Heart
Lantheus Holdings is a leader in medical diagnostics, specifically radiopharmaceuticals and imaging contrast agents. Their products help doctors "see" diseases, particularly in cardiology and oncology. This chart shows how their innovative, patent-protected diagnostic solutions provide the company with high operating margins in the medtech sector.
Market marginality as a whole
Lantheus Holdings, Inc. is a leader in medical diagnostics, producing radiopharmaceuticals and contrast agents for imaging. The company's profitability depends on innovation and the demand for accurate diagnostics. This chart shows overall profitability, but for LNTH, the growing role of diagnostic imaging in medicine ensures a strong market position.
Employees in the company, segment and market as a whole
Number of employees in the company Lantheus Holdings Inc.
Lantheus Holdings is a leader in diagnostic imaging and targeted radiotherapy. This chart shows the growth of its scientific and commercial teams. This increase, particularly following the success of its key products, reflects the high demand for innovative solutions in nuclear medicine.
Share of the company's employees Lantheus Holdings Inc. within the market segment - Heart
Lantheus Holdings is a leader in medical diagnostics, particularly cardiac imaging. The development and production of radiopharmaceuticals and contrast agents requires a highly specialized team. This reflects its key role as an employer in the advanced diagnostic technology niche.
Number of employees in the market segment - Heart
Lantheus Holdings is a leader in diagnostic imaging and targeted radiotherapy. This chart shows employment in the cardiac equipment and diagnostics sector. The growing number of specialists in this field reflects the development of early disease diagnosis methods and the introduction of personalized medicine, which are the core of Lantheus's business.
Number of employees in the market as a whole
Lantheus Holdings, Inc. is a leader in medical diagnostics, particularly in cardiology. While demand for their products is driven by medical needs, a strong economy, as illustrated in this chart, ensures stable hospital funding and broad insurance coverage, facilitating the adoption of advanced diagnostic methods.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Lantheus Holdings Inc. (LNTH)
Lantheus Holdings is a leader in diagnostic imaging and targeted radiotherapy. It is a high-tech medical device company. The very high market capitalization per employee, visible in this chart, reflects the value of its intellectual property, drug portfolio, and manufacturing know-how, which enable it to create unique diagnostic and therapeutic products.
%20of%20the%20company%20Lantheus%20Holdings%20Inc.%20(LNTH)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Lantheus-Holdings-Inc.-LNTH&v=1772648321980 "Chart of market capitalization per employee (in thousands of dollars) of the company Lantheus Holdings Inc. (LNTH)")
Market capitalization per employee (in thousands of dollars) in the market segment - Heart
Lantheus (LNTH) is a leader in radiopharmaceuticals and diagnostic agents (e.g., Definity for cardiac ultrasound). It's a sticky, high-margin, and logistically challenging business (short isotope lifespans). This chart shows the market value per employee in this unique medical niche.
%20by%20market%20segment%20-%20Heart&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Heart&v=1772648321991 "Market capitalization per employee (in thousands of dollars) by market segment - Heart")
Market capitalization per employee (in thousands of dollars) for the overall market
Lantheus Holdings, Inc. is a leader in medical diagnostics, particularly in the development of radiopharmaceuticals for cardiovascular and oncological imaging. Their products help doctors "see" diseases. The chart shows the high market valuation of the company, whose innovations are changing approaches to diagnostics.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772648321995 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Lantheus Holdings Inc. (LNTH)
Lantheus Holdings (LNTH) is a leader in diagnostic imaging and targeted radiotherapy. Their products (such as PYLARIFY for prostate cancer scanning) are critical to medicine. This chart demonstrates how efficiently their R&D team and commercial division can develop and market these high-tech radiopharmaceuticals, generating high profits.
%20Chart%20Lantheus%20Holdings%20Inc.%20(LNTH)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Lantheus-Holdings-Inc.-LNTH&v=1772648322006 "Company Profit Per Employee (in thousands of dollars) Chart Lantheus Holdings Inc. (LNTH)")
Profit per employee (in thousands of dollars) in the market segment - Heart
Lantheus (LNTH) is a "radiopharma." They produce "contrast" agents (for ultrasound and PET scans) and "targeted" radioactive drugs (for cancer treatment). This chart shows the benchmark for "Heart" (Radiopharm). In this sector, the benchmark is *very* high. It's a "B2B consumable," where profit per employee is generated by "proprietary" chemistry.
%20in%20the%20market%20segment%20-%20Heart&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Heart&v=1772648322016 "Chart of profit per employee (in thousands of dollars) in the market segment - Heart")
Profit per employee (in thousands of dollars) for the market as a whole
Lantheus (LNTH) is a leader in diagnostic imaging and radiopharmaceuticals. Their products (e.g., DEFINITY, PYLARIFY) help doctors diagnose heart disease and cancer. This chart, showing average profit per employee, provides context. It helps understand how profitable the medical diagnostics sector, which relies on R&D and complex manufacturing, is relative to its employees.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772648322026 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Lantheus Holdings Inc. (LNTH)
Lantheus Holdings is a leader in the development of diagnostic and therapeutic radiopharmaceuticals, particularly for cardiology and oncology. This chart demonstrates the value of its innovative products. Its high revenue per employee reflects its strong market position and ability to monetize unique medical technologies.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Lantheus-Holdings-Inc.-LNTH&v=1772648322031 "Sales chart per company employee Lantheus Holdings Inc. (LNTH)")
Sales per employee in the market segment - Heart
Lantheus Holdings is a leader in diagnostic imaging. They produce radiopharmaceuticals and contrast agents (such as Definity), which help doctors "see" the heart and cancer. This chart shows revenue per employee. The comparison with the sector reflects the demand and productivity of their niche diagnostic products.
Sales per employee for the market as a whole
Lantheus Holdings (LNTH) is a leader in medical diagnostics, particularly in radiology and cardiology. They produce diagnostic agents (contrast agents) and radiopharmaceuticals. They are a specialized pharmaceutical business. This chart shows how effectively their commercial and manufacturing teams generate revenue from these niche but critically important products.
Short shares by company, segment and market as a whole
Shares shorted by company Lantheus Holdings Inc. (LNTH)
Lantheus Holdings is a leader in diagnostic imaging. They produce contrast agents (such as Definity) and radiopharmaceuticals that help doctors "see" heart disease and cancer. It's a fast-growing market. This chart shows the number of investors who consider the company's shares overvalued or are wary of competition.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Lantheus-Holdings-Inc.-LNTH&v=1772648322043 "Short Shares Chart for the Company Lantheus Holdings Inc. (LNTH)")
Shares shorted by market segment - Heart
Lantheus Holdings (LNTH) is a leader in medical diagnostics. They produce radiopharmaceuticals and contrast agents (for example, for cardiac ultrasound) that help "see" diseases. This chart shows bets against the diagnostics sector. It may reflect concerns about competition (for example, the emergence of generics) or manufacturing issues.
Shares shorted by the overall market
Lantheus (LNTH) produces diagnostic medical products. This Short_All chart shows systemic pessimism. When it rises, even "defensive" sectors like healthcare are sold off. This fear of a correction is weighing on LNTH, despite the fact that its products are vital.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Lantheus Holdings Inc. (LNTH)
Lantheus Holdings produces diagnostic and radiopharmaceutical products. The business benefits from growing demand for precision diagnostics. This chart shows LNTH above 70, which may reflect strong sales of key products or successful R&D. Below 30, this may reflect concerns about competition or supply issues.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Lantheus-Holdings-Inc.-LNTH&v=1772648322055 "RSI 14 indicator chart for the company's stock Lantheus Holdings Inc. (LNTH)")
RSI 14 Market Segment - Heart
Lantheus (LNTH) is a leader in imaging agents. They produce contrast agents that make ultrasounds and PET scans (for heart and cancer) clear. The RSI_14_Seg for their diagnostics segment shows the "temperature." This helps us understand whether LNTH's growth is due to their blockbuster PYLARIFY or a general overheating in medtech.
RSI 14 for the overall market
Lantheus (LNTH) specializes in diagnostic imaging (radiopharmaceuticals). This chart shows hospital and patient readiness for these expensive procedures. During periods of euphoria and stability in the healthcare system, these procedures are in demand. During times of panic and crisis (such as a pandemic), routine diagnostics may be postponed, reducing demand.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast LNTH (Lantheus Holdings Inc.)
Lantheus Holdings (LNTH) is a leader in diagnostic imaging and radiopharmaceuticals. Their key product, PYLARIFY, is used for PET scanning of prostate cancer. This chart reflects the analyst consensus on how quickly PYLARIFY's use will grow and the potential of the company's other drugs in development.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-LNTH-Lantheus-Holdings-Inc.&v=1772648322078 "A chart showing analyst consensus forecasts for the expected stock price. LNTH (Lantheus Holdings Inc.)")
The difference between the consensus estimate and the actual stock price LNTH (Lantheus Holdings Inc.)
Lantheus is a leader in medical imaging. The company produces radiopharmaceuticals (contrast agents) and microspheres that highlight the heart and cancer during scans (PET, ultrasound). This chart shows the difference between the consensus forecast and the price. It reflects analysts' belief in the growth of the precision diagnostics market.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-LNTH-Lantheus-Holdings-Inc.&v=1772648322087 "A chart showing the difference between the consensus forecast and the actual stock price. LNTH (Lantheus Holdings Inc.)")
Analyst consensus forecast for stock prices by market segment - Heart
Lantheus is a leader in radiopharmaceuticals and diagnostic imaging. The company produces contrast agents and isotopes that highlight the heart or cancerous tumors on images. This chart shows analysts' overall expectations for the heart (cardiology) sector. It reflects whether experts believe the medical diagnostics market will grow.
Analysts' consensus forecast for the overall market share price
Lantheus Holdings is a leader in diagnostic imaging. They produce radiopharmaceuticals (contrast agents) that help highlight heart disease and cancer during scans. This chart shows overall market sentiment. For Lantheus, a company in innovative medical technology, it's important to understand how these expectations impact hospital budgets for advanced diagnostics. (348)
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Lantheus Holdings Inc.
Lantheus (LNTH) is a dominant company in the medical imaging niche. They produce radiopharmaceuticals (contrast agents) and microspheres used in diagnostic imaging, particularly cardiology (heart ultrasound). This chart reflects their dominance. It measures the volume of diagnostic procedures and the growing demand for their key product, PYLARIFY for prostate cancer imaging.
AKIMA Market Segment Index - Heart
Lantheus is a leader in radiopharmaceuticals and diagnostics; the company produces contrast agents (Definity) for cardiac ultrasound and innovative drugs for cancer diagnostics and treatment (PET). This composite metric evaluates companies. The graph shows the sector average. This benchmark: how does LNTH's niche (radiopharmaceutical) model differentiate it from the average competitor?
The AKIM Index for the overall market
Lantheus is a leader in diagnostic imaging. The company produces contrast agents (Pylarify) for PET scanning (especially for prostate cancer). This chart, which reflects the market average, is a backdrop. It helps assess how this defensive (non-cyclical) growth story in healthcare compares to general macroeconomic fluctuations.
